You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,107,458


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,107,458
Title: Cyclic hexapeptides having antibiotic activity
Abstract:This invention relates to new polypeptide compounds represented by the following formula (I): ##STR1## wherein R.sup.1 is as defined in the description and pharmaceutically acceptable salt thereof which have antimicrobial activities (especially, antifungal activities), inhibitory activity on .beta.-1,3-glucan synthase, to process for preparation thereof, to a pharmaceutical composition comprising the same, and to a method for the prophylactic and/or therapeutic treatment of infectious diseases including Pneumocystis carinii infection (e.g. Pneumocystis carinii pneumonia) in a human being or an animal.
Inventor(s): Ohki; Hidenori (Takarazuka, JP), Tomishima; Masaki (Minoo, JP), Yamada; Akira (Fujiidera, JP), Takasugi; Hisashi (Sakai, JP)
Assignee: Fujisawa Pharmaceutical Co., Ltd. (Osaka, JP)
Application Number:08/809,723
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,107,458: A Detailed Analysis

Introduction

United States Patent 6,107,458, titled "Method and System for Automatically Analyzing and Displaying Data from Any of Multiple Sources," is a patent that has been subject to significant scrutiny under the patent eligibility criteria outlined in 35 U.S.C. § 101. This analysis will delve into the patent's claims, the patent landscape, and the implications of recent legal and regulatory updates.

Background of the Patent

The patent in question, 6,107,458, was granted to Electric Power Group, LLC, and involves methods and systems for detecting events on an interconnected electric power grid in real time. The patent claims cover the collection, analysis, and display of data from multiple sources, which is a critical function in the management and operation of power grids.

Claims Analysis

Claim Structure

The claims of the patent, such as Claim 12 of the ’710 patent, are representative of the broader issues with patent eligibility under § 101. Claim 12 reads: "A method of detecting events on an interconnected electric power grid in real time over a wide area and automatically analyzing the events on the interconnected electric power grid, the method comprising: receiving a plurality of data streams, analyzing the data streams, and displaying the results."[5]

Eligibility Under § 101

The eligibility of these claims under § 101 has been challenged. The Federal Circuit Court has affirmed the district court's summary judgment that the subject matter of these claims fails the tests for patent eligibility. The court reasoned that the claims do not go beyond requiring the collection, analysis, and display of available information in a particular field, without limiting them to technical means for performing these functions that are arguably an advance over conventional computer and network technology[5].

Judicial Exceptions and Practical Applications

Abstract Ideas and Judicial Exceptions

The claims in question involve abstract ideas related to data collection, analysis, and display. According to the Supreme Court's decision in Alice Corp. v. CLS Bank Int’l, laws of nature, natural phenomena, and abstract ideas are not patentable. The claims must integrate these abstract ideas into a practical application to be considered patent-eligible[5].

Practical Applications

The 2024 USPTO guidance update emphasizes the importance of practical applications in determining patent eligibility. For a claim to be patent-eligible, it must specify the use of the abstract idea in a way that provides concrete benefits or solves specific problems in the relevant field. In the case of Patent 6,107,458, the claims do not meet this criterion as they merely describe general functions without limiting them to specific technical means or practical applications[1].

Recent USPTO Guidance and Its Implications

Enhanced Focus on Practical Applications

The 2024 USPTO guidance update refines the process for determining the patent eligibility of AI-related inventions and other technologies. It highlights the need to evaluate whether a claim integrates a judicial exception into a practical application. This involves assessing additional elements in the claim to determine if they impose meaningful limits on the exception, transforming the claim into patent-eligible subject matter[1].

AI-Assisted Inventions

The update also clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies. This distinction is crucial as it ensures that AI’s role as a tool does not exclude inventions from eligibility, provided there is significant human contribution[1].

Patent Landscape and Precedents

Federal Circuit and Supreme Court Precedents

The Federal Circuit and Supreme Court have set significant precedents in determining patent eligibility. Cases like Electric Power Group, LLC v. Alstom S.A. and Alice Corp. v. CLS Bank Int’l have established that claims must go beyond abstract ideas and involve inventive concepts or practical applications to be patent-eligible. These precedents have shaped the current patent landscape and influence how claims are constructed and evaluated[5].

Impact on Patent Scope and Quality

The debates over patent quality and scope are ongoing. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process tends to narrow the scope of patent claims, ensuring that they are more specific and less likely to be overly broad or vague[3].

Practical Applications in Similar Patents

Example from the 2024 USPTO Guidance

The 2024 USPTO guidance provides examples that illustrate the difference between patent-eligible and ineligible claims. For instance, Claim 2 in the guidance specifies the use of separated audio components in a real-time speech recognition system to enhance the accuracy of voice commands in hands-free environments. This claim is considered patent-eligible because it integrates the abstract idea into a practical application, providing tangible benefits such as improved noise reduction and accuracy in speech recognition[1].

Key Takeaways

  • Patent Eligibility Criteria: Claims must integrate abstract ideas into practical applications to be patent-eligible.
  • Practical Applications: Specifying the use of abstract ideas in a way that provides concrete benefits or solves specific problems is crucial.
  • AI-Assisted Inventions: The use of AI in invention development does not impact subject matter eligibility, provided there is significant human contribution.
  • Federal Circuit and Supreme Court Precedents: Cases like Electric Power Group, LLC v. Alstom S.A. and Alice Corp. v. CLS Bank Int’l set the framework for evaluating patent eligibility.

FAQs

Q: What are the key criteria for determining patent eligibility under § 101?

A: The key criteria include integrating abstract ideas into practical applications and ensuring that the claims impose meaningful limits on judicial exceptions, transforming them into patent-eligible subject matter.

Q: How does the use of AI impact the patent eligibility of an invention?

A: The use of AI in invention development does not impact subject matter eligibility, provided there is significant human contribution. The focus remains on the claimed invention itself.

Q: What is the significance of the 2024 USPTO guidance update on AI patent eligibility?

A: The update refines the process for determining patent eligibility, emphasizing the integration of judicial exceptions into practical applications and clarifying the role of AI in invention development.

Q: How do Federal Circuit and Supreme Court precedents influence patent eligibility?

A: Precedents from cases like Electric Power Group, LLC v. Alstom S.A. and Alice Corp. v. CLS Bank Int’l establish that claims must go beyond abstract ideas and involve inventive concepts or practical applications to be patent-eligible.

Q: What metrics are used to measure patent scope and quality?

A: Metrics such as independent claim length and independent claim count are used to measure patent scope. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility - Mintz
  2. Patent Claim Construction in the Federal Circuit, 2024 ed - Thomson Reuters
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO
  5. Electric Power Group, LLC v. Alstom S.A. - Federal Circuit Court of Appeals

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,107,458

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,107,458

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9420425Oct 17, 1994
United Kingdom9508745Apr 28, 1995
PCT Information
PCT FiledSeptember 29, 1995PCT Application Number:PCT/JP95/01983
PCT Publication Date:April 18, 1996PCT Publication Number: WO96/11210

International Family Members for US Patent 6,107,458

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0788511 ⤷  Subscribe CA 2008 00030 Denmark ⤷  Subscribe
European Patent Office 0788511 ⤷  Subscribe 91452 Luxembourg ⤷  Subscribe
European Patent Office 0788511 ⤷  Subscribe 300352 Netherlands ⤷  Subscribe
European Patent Office 0788511 ⤷  Subscribe SPC022/2008 Ireland ⤷  Subscribe
European Patent Office 0788511 ⤷  Subscribe 08C0028 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.